These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 8886511)
21. Cross-sectional associations of albuminuria among Aboriginal and Torres Strait Islander adults: the eGFR Study. Hughes JT; Maple-Brown LJ; Thomas M; Lawton PD; Sinha A; Cass A; Barzi F; Jones G; Jerums G; MacIsaac RJ; O'Dea K; Hoy WE Nephrology (Carlton); 2018 Jan; 23(1):37-45. PubMed ID: 29250918 [TBL] [Abstract][Full Text] [Related]
22. Albuminuria and incident coronary heart disease in Australian Aboriginal people. Wang Z; Hoy WE Kidney Int; 2005 Sep; 68(3):1289-93. PubMed ID: 16105063 [TBL] [Abstract][Full Text] [Related]
23. Physical and biochemical predictors of death in an Australian aboriginal cohort. McDonald SP; Wang Z; Hoy WE Clin Exp Pharmacol Physiol; 1999 Aug; 26(8):618-21. PubMed ID: 10474776 [TBL] [Abstract][Full Text] [Related]
24. Associations of mortality and cardiovascular disease risks with diabetes and albuminuria in urban Indigenous Australians: the DRUID follow-up study. Barr ELM; Cunningham J; Tatipata S; Dunbar T; Kangaharan N; Guthridge S; Li SQ; Condon JR; Shaw JE; O'Dea K; Maple-Brown LJ Diabet Med; 2017 Jul; 34(7):946-957. PubMed ID: 28375555 [TBL] [Abstract][Full Text] [Related]
25. Renal disease in the Aboriginal community of Woorabinda. Hazel TJ; Hill PS Aust J Rural Health; 2006 Feb; 14(1):20-3. PubMed ID: 16426428 [TBL] [Abstract][Full Text] [Related]
26. Time to abandon microalbuminuria? Ruggenenti P; Remuzzi G Kidney Int; 2006 Oct; 70(7):1214-22. PubMed ID: 16871239 [TBL] [Abstract][Full Text] [Related]
27. Is a reduction in albuminuria associated with renal and cardiovascular protection? A post hoc analysis of the ALTITUDE trial. Heerspink HJ; Ninomiya T; Persson F; Brenner BM; Brunel P; Chaturvedi N; Desai AS; Haffner SM; Mcmurray JJ; Solomon SD; Pfeffer MA; Parving HH; de Zeeuw D Diabetes Obes Metab; 2016 Feb; 18(2):169-77. PubMed ID: 26511599 [TBL] [Abstract][Full Text] [Related]
28. Evidence for benefits of perindopril in hypertension and its complications. Laurent S Am J Hypertens; 2005 Sep; 18(9 Pt 2):155S-162S. PubMed ID: 16125052 [TBL] [Abstract][Full Text] [Related]
29. The DD genotype of the angiotensin-converting enzyme gene occurs in very low frequency in Australian Aboriginals. Lester S; Heatley S; Bardy P; Bahnisch J; Bannister K; Faull R; Clarkson A Nephrol Dial Transplant; 1999 Apr; 14(4):887-90. PubMed ID: 10328464 [TBL] [Abstract][Full Text] [Related]
30. Antecedents of renal disease in Aborigines. Thomas M Nephrology (Carlton); 2004 Dec; 9 Suppl 4():S113-6. PubMed ID: 15601400 [TBL] [Abstract][Full Text] [Related]
31. Proteinuria and cardiovascular disease. Weinstock Brown W; Keane WF Am J Kidney Dis; 2001 Oct; 38(4 Suppl 1):S8-S13. PubMed ID: 11576914 [TBL] [Abstract][Full Text] [Related]
32. Kidney volume, blood pressure, and albuminuria: findings in an Australian aboriginal community. Singh GR; Hoy WE Am J Kidney Dis; 2004 Feb; 43(2):254-9. PubMed ID: 14750090 [TBL] [Abstract][Full Text] [Related]
33. Carotid intima-media thickness, cardiovascular risk factors and albuminuria in a remote Australian Aboriginal community. McDonald SP; Maguire GP; Duarte N; Wang XL; Hoy WE Atherosclerosis; 2004 Dec; 177(2):423-31. PubMed ID: 15530919 [TBL] [Abstract][Full Text] [Related]
34. Early chronic kidney disease in Aboriginal and non-Aboriginal Australian children: remoteness, socioeconomic disadvantage or race? Haysom L; Williams R; Hodson E; Roy LP; Lyle D; Craig JC Kidney Int; 2007 Apr; 71(8):787-94. PubMed ID: 17311073 [TBL] [Abstract][Full Text] [Related]
35. Post-streptococcal glomerulonephritis is a strong risk factor for chronic kidney disease in later life. Hoy WE; White AV; Dowling A; Sharma SK; Bloomfield H; Tipiloura BT; Swanson CE; Mathews JD; McCredie DA Kidney Int; 2012 May; 81(10):1026-1032. PubMed ID: 22297679 [TBL] [Abstract][Full Text] [Related]
36. Therapeutic safety of perindopril in the treatment of mild hypertension with concomitant nephropathy. Bönner G; Lederle RM; Scholze J; Stumpe KO Arzneimittelforschung; 1993 Aug; 43(8):852-5. PubMed ID: 8216441 [TBL] [Abstract][Full Text] [Related]
37. The kidney, a cardiovascular risk marker, and a new target for therapy. de Zeeuw D; Hillege HL; de Jong PE Kidney Int Suppl; 2005 Sep; (98):S25-9. PubMed ID: 16108967 [TBL] [Abstract][Full Text] [Related]
38. The natural history of renal disease in Australian Aborigines. Part 1. Changes in albuminuria and glomerular filtration rate over time. Hoy WE; Wang Z; VanBuynder P; Baker PR; Mathews JD Kidney Int; 2001 Jul; 60(1):243-8. PubMed ID: 11422757 [TBL] [Abstract][Full Text] [Related]
39. Reducing premature death and renal failure in Australian aboriginals: a community-based cardiovascular and renal protective program. McLaren B Med J Aust; 2001 Feb; 174(4):201-2. PubMed ID: 11270767 [No Abstract] [Full Text] [Related]
40. Albuminuria in Australian Aboriginal people: prevalence and associations with components of the metabolic syndrome. Rowley KG; Iser DM; Best JD; O'Dea K; Leonard D; McDermott R Diabetologia; 2000 Nov; 43(11):1397-403. PubMed ID: 11126409 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]